Back

Ventricular fibrillation amplitude analysis and comparison for transvenous ICD and extravascular ICD systems

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Device therapy e-posters Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Miss Yuanzhen Liu

Medtronic, Minneapolis (United States of America)

42 More presentations in this session

Presentation thumbnail
Intraoperative echocardiography for electrode implantation into the left bundle branch region in patients with indications for cardiac resynchronization therapy
Doctor N. Pavlinova (Odessa, UA)
Abstract Slides
Presentation thumbnail
Adherence to guidelines of diagnostic and therapeutic practices for suspected infections of cardiac implantable electronic devices
Doctor G. De Ciancio (NANCY, FR)
Abstract Slides
Presentation thumbnail
Prognostic effect of the electrocardiographic pattern following cardiac resincronization
Mr J. Asensio Nogueira (Burgos, ES)
Abstract Slides
Presentation thumbnail
Single- vs dual-chamber ICDs to prevent from inappropriate shocks: the debate is still alive
Doctor S. Briongos Figuero (Madrid, ES)
Abstract Slides
Presentation thumbnail
Validation of leadless atrioventricular synchronous pacing with Holter-ECG: a pilot study
Doctor S. Briongos Figuero (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Device therapy e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Cross-vendor performance of ventricular fibrillation detection by implantable cardioverter-defibrillators: insights from a patient-signal injection benchmark model
13 April 2026
thumbnail
Webinar
Extravascular ICD: why, how, and for which patients?
20 October 2025
thumbnail
Congress Presentation
QRS fragmentation and low voltage ECG in arrhythmogenic cardiomyopathy.
29 June 2021
thumbnail
Congress Presentation
Transvenous lead vs epicardial lead: Impact of the different approach in cardiac resynchronization therapy
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources